Skip navigation
>»
RSS feed for this page
Know something we don't? Submit a conference announcement
Choose Category:

Hepatology meetings & conferences

5 meetings & conferences listed in Hepatology 

4th Workshop on HCV Therapy Advances – New Antivirals in Clinical Practice
France
12/12/2014

4th Workshop on HCV Therapy Advances – New Antivirals in Clinical Practice

12-13 December 2014 Paris, France

The fourth edition of the Workshop on HCV Therapy Advances – New Antivirals in Clinical Practice will be held in Paris, France on 12-13 December 2014.

An exciting program has been set for treating physicians to discuss the latest developments in the field of Hepatitis C treatment and the promising new treatment possibilities of new direct antivirals that are becoming available. The conference presentations will focus on the translation of these new data and availability of new drugs into daily clinical practice.

Case discussions will be an important part of this conference in order to allow discussions on local issues and stimulate interaction.

Hepatologist, Physician
Americas Hepato-Pancreato-Biliary Association 2015 Annual Meeting
United States
Florida
03/11/2015

Americas Hepato-Pancreato-Biliary Association 2015 Annual Meeting

March 11-15, 2015 Miami Beach, Florida

Hepatologist, Physician, Physician Researcher, Surgeon
Liver Metabolism and Nonalcoholic Fatty Liver Disease (NAFLD)
Canada
03/22/2015

Liver Metabolism and Nonalcoholic Fatty Liver Disease (NAFLD)

Joint with the meeting on Obesity and the Metabolic Syndrome: Mitochondria and Energy Expenditure

March 22—27, 2015 Whistler, British Columbia, Canada

Registered attendees of one meeting in a joint pair may participate in sessions of the other, pending space availability.

Abnormalities in hepatic intermediary metabolism are common in obesity and are a significant source of morbidity and mortality in obese people. For example, nonalcoholic fatty liver disease (NAFLD) affects over 25% of the US population and has become the most common cause of liver failure and transplantation. NAFLD is also linked to the development of major metabolic diseases such as type 2 diabetes and cardiovascular diseases. Despite the central role of the liver in whole-body energy metabolism and its contribution to disease development, there are literally no dedicated meetings that focus on the cellular and mechanistic aspects of the regulation of liver metabolism. This meeting will bring together experts, both basic scientists and clinicians, across diverse fields including biochemistry, cell biology, genetics, hepatology, nutrition, physiology and virology to exclusively focus on the liver and bridge a translational divide. Meeting themes will center on regulation of hepatic energy metabolism, crosstalk between the liver and different organs and cell types and how alterations in macronutrient metabolism contribute to disease etiology. The objectives of this conference are to: 1) Expose scientists across diverse disciplines to different aspects of hepatic metabolism and NAFLD development; 2) Find synergies in research efforts to expedite our understand hepatic energy metabolism; and 3) Explore emerging metabolic targets for therapeutic interventions to prevent or alleviate NAFLD and related comorbidities.

Biochemist, Cell Biologist, Geneticist , Hepatologist, Molecular Biologist, Nutritionist, Physician Researcher, Physiologist, Virologist
15th International Symposium on Viral Hepatitis and Liver Diseases (ISVHLD)
Germany
06/26/2015

15th International Symposium on Viral Hepatitis and Liver Diseases (ISVHLD)

June 26-28, 2015 Berlin, Germany

In June 2015 the 15th International Symposium on Viral Hepatitis and Liver Diseases (ISVHLD) will be held in Berlin, Germany.

ISVHLD has a tradition of 43 years. Initially the focus was on discovery of hepatitis viruses, then it was the development of diagnostic procedures, vaccines, understanding pathophysiology and now therapies. In 2015 will be the time when many of the new direct antiviral agents (DAAs) against hepatitis C will be approved. However public health will become very important to identify the patients in need for therapy and to make these new therapies accessible to all parts of the world. Furthermore we still need to develop better finite therapies for hepatitis B and need to address many more burning issues of global relevance like hepatitis D and E.

This symposium is organized every three years moving around the continents. Basic scientists and clinicians will discuss the most recent advances made against the global health burden caused by all hepatitis viruses. For the first time the symposium will be organized in Germany taking place in its capital Berlin.

Hepatologist, Physician, Physician Researcher, Virologist
5th Biennial Congress of the Asian-Pacific Hepato-Pancreato-Biliary Association
Singapore
03/18/2015

5th Biennial Congress of the Asian-Pacific Hepato-Pancreato-Biliary Association

March 18-21, 2015 Singapore

The 5th Biennial Congress of the Asian-Pacific Hepato-Pancreato-Biliary Association (A-PHPBA) is one of region’s largest medical conferences dedicated to the study of liver, pancreas and biliary discipline. The event provides medical professionals an excellent platform for the exchange of clinical and scientific knowledge on the latest developments and emerging challenges of hepato-pancreato-biliary (HPB) disorders.

The four-day congress will feature an exciting line-up of expert speakers including top practitioners, opinion leaders and researchers. Delegates can look forward to an intensive knowledge-sharing event comprising plenary sessions, oral presentations and video screenings. There will be a host of networking opportunities for delegates to rub shoulders with top experts and opinion leaders.

Congress Secretariat for the 5th Biennial Congress of the Asian-Pacific Hepato-Pancreatro-Biliary Association
Tel: +65 6393 0202
Fax: +65 6292 7577
Email: info@aphpba2015.com
Website: www.aphpba2015.com

Hepatologist, Physician, Physician Researcher